FDA Inspection 1125668 — Adam S. Giermasz, M.D., Ph.D.
The FDA completed an inspection of Adam S. Giermasz, M.D., Ph.D. on Jul 17, 2020 in Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 17, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Sacramento, CA (United States)
Additional Details
Clinical Investigator (CI)